Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A00638 | 35018944 | Food Funct | Ginsenoside CK ameliorates hepatic lipid accumulation via activating the LKB1/AMPK pathway in vitro and in vivo. | 2022 | Details |
| A00639 | 35018737 | Hepatol Commun | Hepatocyte TGF-β Signaling Inhibiting WAT Browning to Promote NAFLD and Obesity Is Associated With Let-7b-5p. | 2022 | Details |
| A00640 | 35018684 | Phytother Res | Banana green peels extract protects against nonalcoholic fatty liver disease in high-fat-fed mice through modulation of lipid metabolism and inflammation. | 2022 | Details |
| A00642 | 35016999 | J Nutr Biochem | Gestational hypercholesterolemia programs hepatic steatosis in a sex-specific manner in ApoE-deficient mice. | 2022 | Details |
| A00643 | 35016856 | Obes Res Clin Pract | High-priority liver transplantation and simultaneous sleeve gastrectomy in MELD 32 end-stage liver disease: a case report with long-term follow-up. | 2022 | Details |
| A00644 | 35016686 | Nutr Metab (Lond) | The role and possible mechanism of the long noncoding RNA LINC01260 in nonalcoholic fatty liver disease. | 2022 | Details |
| A00645 | 35016619 | BMC Geriatr | Is there an association between non-alcoholic fatty liver disease and cognitive function? A systematic review. | 2022 | Details |
| A00647 | 35015019 | Food Funct | Preventive effects of black soybean polyphenols on non-alcoholic fatty liver disease in three different mouse models. | 2022 | Details |
| A00648 | 35015002 | Food Funct | Higher serum vitamin A is associated with a worsened progression of non-alcoholic fatty liver disease in adults: a prospective study. | 2022 | Details |
| A00649 | 35014850 | Nutr Hosp | [ESPEN Practical Guideline: Clinical nutrition in liver disease]. | 2022 | Details |
| A00650 | 35014168 | Basic Clin Pharmacol Toxicol | Efficacy of fibroblast growth factor 21 in non-alcoholic fatty liver disease in guinea pigs. | 2022 | Details |
| A00651 | 35014161 | Diabetes Obes Metab | The metabolic triad of non-alcoholic fatty liver disease, visceral adiposity and type 2 diabetes: Implications for treatment. | 2022 | Details |
| A00652 | 35014156 | Diabetes Obes Metab | Inhibition of 11β-Hydroxysteroid dehydrogenase-1 with AZD4017 in patients with nonalcoholic steatohepatitis or nonalcoholic fatty liver disease: A randomized, double-blind, placebo-controlled, phase II study. | 2022 | Details |
| A00653 | 35014145 | Diabetes Obes Metab | Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for type 2 diabetes (EDICT). | 2022 | Details |
| A00654 | 35013596 | Nat Rev Nephrol | Association of metabolic dysfunction-associated fatty liver disease with kidney disease. | 2022 | Details |
| A00655 | 35013582 | Sci Rep | PRMT3 inhibitor SGC707 reduces triglyceride levels and induces pruritus in Western-type diet-fed LDL receptor knockout mice. | 2022 | Details |
| A00656 | 35013417 | Sci Rep | Different sites of actions make different responses to thiazolidinediones between mouse and rat models of fatty liver. | 2022 | Details |
| A00657 | 35013082 | AIDS | Prevalence of non-alcoholic fatty liver disease using non-invasive techniques among children, adolescents, and youths living with HIV. | 2022 | Details |
| A00658 | 35013040 | J Oleo Sci | Pink Lotus Essential Oil and Alleviates on Free Fatty Acid Induced Steatosis in HepG2 Cells via PI3K/Akt and NF-κB Pathways. | 2022 | Details |
| A00659 | 35011784 | J Clin Med | Triglyceride Glucose-Waist Circumference Is Superior to the Homeostasis Model Assessment of Insulin Resistance in Identifying Nonalcoholic Fatty Liver Disease in Healthy Subjects. | 2021 | Details |
| A00660 | 35011746 | J Clin Med | Modulation of Bile Acid Metabolism to Improve Plasma Lipid and Lipoprotein Profiles. | 2021 | Details |
| A00661 | 35011625 | Cells | The Nuclear Receptor PXR in Chronic Liver Disease. | 2021 | Details |
| A00662 | 35011585 | Cells | Cynanchum atratum Alleviates Non-Alcoholic Fatty Liver by Balancing Lipogenesis and Fatty Acid Oxidation in a High-Fat, High-Fructose Diet Mice Model. | 2021 | Details |
| A00663 | 35010976 | Nutrients | Metabolic-Associated Fatty Liver Disease (MAFLD), Diabetes, and Cardiovascular Disease: Associations with Fructose Metabolism and Gut Microbiota. | 2021 | Details |
| A00664 | 35010966 | Nutrients | Effect of Different Types of Intermittent Fasting on Biochemical and Anthropometric Parameters among Patients with Metabolic-Associated Fatty Liver Disease (MAFLD)-A Systematic Review. | 2021 | Details |
| A00665 | 35010950 | Nutrients | Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and Apoptosis. | 2021 | Details |
| A00666 | 35010924 | Nutrients | Lactoferrin Prevents Hepatic Injury and Fibrosis via the Inhibition of NF-κB Signaling in a Rat Non-Alcoholic Steatohepatitis Model. | 2021 | Details |
| A00667 | 35010923 | Nutrients | Association between Non-Alcoholic Fatty Liver Disease and Mediterranean Lifestyle: A Systematic Review. | 2021 | Details |
| A00668 | 35009003 | Int J Mol Sci | Heat Shock Protein 60 Restricts Release of Mitochondrial dsRNA to Suppress Hepatic Inflammation and Ameliorate Non-Alcoholic Fatty Liver Disease in Mice. | 2022 | Details |
| A00669 | 35008925 | Int J Mol Sci | Non-Alcoholic Steatohepatitis (NASH) and Organokines: What Is Now and What Will Be in the Future. | 2022 | Details |
| A00670 | 35008852 | Int J Mol Sci | Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases. | 2021 | Details |
| A00671 | 35008682 | Int J Mol Sci | Emerging Roles of Calcium Signaling in the Development of Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A00673 | 35007752 | J Biomed Inform | Stratifying individuals into non-alcoholic fatty liver disease risk levels using time series machine learning models. | 2022 | Details |
| A00674 | 35007392 | Liver Int | Ferroptosis and metabolic dysfunction-associated fatty liver disease: Is there a link? | 2022 | Details |
| A00675 | 35006629 | Hepatology | Progressive loss of hepatocyte nuclear factor 4 alpha activity in chronic liver diseases in humans. | 2022 | Details |
| A00676 | 35005800 | Aliment Pharmacol Ther | A sequential approach using the age-adjusted fibrosis-4 index and vibration-controlled transient elastography to detect advanced fibrosis in Korean patients with non-alcoholic fatty liver disease. | 2022 | Details |
| A00677 | 35005749 | Food Funct | Protective effect of orange essential oil on the formation of non-alcoholic fatty liver disease caused by high-fat diet. | 2022 | Details |
| A00678 | 35005119 | Genes Dis | Comparison of hepatic gene expression profiles between three mouse models of Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A00679 | 35005107 | Genes Dis | Critical roles of FTO-mediated mRNA m6A demethylation in regulating adipogenesis and lipid metabolism: Implications in lipid metabolic disorders. | 2021 | Details |
| A00682 | 35004947 | Hepatobiliary Surg Nutr | The presence of NAFLD in nonobese subjects increased the risk of metabolic abnormalities than obese subjects without NAFLD: a population-based cross-sectional study. | 2021 | Details |
| A00683 | 35004861 | Front Mol Biosci | Beyond the Liver: Liver-Eye Communication in Clinical and Experimental Aspects. | 2021 | Details |
| A00684 | 35004736 | Front Med (Lausanne) | Association Between Helicobacter Pylori Infection and Non-alcoholic Fatty Liver Disease, Hepatic Adipose Deposition and Stiffness in Southwest China. | 2021 | Details |
| A00685 | 35004133 | Anal Cell Pathol (Amst) | MicroRNA-137-3p Improves Nonalcoholic Fatty Liver Disease through Activating AMPKα. | 2021 | Details |
| A00686 | 35003876 | Biomed Opt Express | Intravital two-photon imaging and quantification of hepatic steatosis and fibrosis in a live small animal model. | 2021 | Details |
| A00687 | 35003513 | Oxid Med Cell Longev | TNF-Like Ligand 1 Aberrance Aggravates Nonalcoholic Steatohepatitis via M1 Macrophage Polarization. | 2021 | Details |
| A00688 | 35003024 | Front Microbiol | Effect of Chinese Herbal Medicine Mixture 919 Syrup on Regulation of the Ghrelin Pathway and Intestinal Microbiota in Rats With Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A00690 | 35002979 | Front Endocrinol (Lausanne) | Hepatocellular Carcinoma and Obesity, Type 2 Diabetes Mellitus, Cardiovascular Disease: Causing Factors, Molecular Links, and Treatment Options. | 2021 | Details |
| A00691 | 35002729 | Front Pharmacol | Mitochondrial Targeting Therapeutics: Promising Role of Natural Products in Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A00692 | 35001468 | Pediatr Diabetes | Organ fat in Latino youth at risk for type 2 diabetes. | 2022 | Details |
| A00693 | 35001345 | J Physiol Biochem | Vaspin attenuates steatosis-induced fibrosis via GRP78 receptor by targeting AMPK signaling pathway. | 2022 | Details |
| A00694 | 35000203 | Hepatology | Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD. | 2022 | Details |
| A00695 | 35000120 | Clin J Gastroenterol | The impact of emricasan on chronic liver diseases: current data. | 2022 | Details |
| A00696 | 34999396 | Int Immunopharmacol | Liensinine alleviates high fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) through suppressing oxidative stress and inflammation via regulating TAK1/AMPK signaling. | 2022 | Details |
| A00697 | 34999330 | Clin Nutr | Red meat consumption, obesity, and the risk of nonalcoholic fatty liver disease among women: Evidence from mediation analysis. | 2021 | Details |
| A00698 | 34998993 | Clin Gastroenterol Hepatol | Association of Physical Activity With Risk of Liver Fibrosis, Sarcopenia, and Cardiovascular Disease in Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A00699 | 34998898 | Mol Cell Endocrinol | Ceramide signaling in the gut. | 2022 | Details |
| A00700 | 34998040 | Eur J Med Chem | Discovery of a tricyclic farnesoid X receptor agonist HEC96719, a clinical candidate for treatment of non-alcoholic steatohepatitis. | 2021 | Details |
| A00701 | 34998036 | Int Immunopharmacol | Dapagliflozin improves steatohepatitis in diabetic rats via inhibition of oxidative stress and inflammation. | 2022 | Details |
| A00702 | 34997649 | J Clin Lab Anal | The association between non-alcoholic fatty liver disease and serum ferritin levels in American adults. | 2022 | Details |
| A00703 | 34997159 | Sci Rep | Evaluation of NAFLD fibrosis, FIB-4 and APRI score in diabetic patients receiving exenatide treatment for non-alcoholic fatty liver disease. | 2022 | Details |
| A00704 | 34996457 | Lipids Health Dis | NAFLD fibrosis score is correlated with PCSK9 and improves outcome prediction of PCSK9 in patients with chest pain: a cohort study. | 2022 | Details |
| A00705 | 34995410 | Liver Int | Roles for the mycobiome in liver disease. | 2022 | Details |
| A00706 | 34994824 | Naunyn Schmiedebergs Arch Pharmacol | The crucial role of oxidative stress in non-alcoholic fatty liver disease-induced male reproductive toxicity: the ameliorative effects of Iranian indigenous probiotics. | 2022 | Details |
| A00707 | 34993581 | J Mol Med (Berl) | A comprehensive review on phytochemicals for fatty liver: are they potential adjuvants? | 2022 | Details |
| A00708 | 34993571 | Diabetologia | Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes: a randomised controlled trial. | 2022 | Details |
| A00709 | 34993389 | Curr Dev Nutr | Considerations When Choosing High-Fat, High-Fructose, and High-Cholesterol Diets to Induce Experimental Nonalcoholic Fatty Liver Disease in Laboratory Animal Models. | 2021 | Details |
| A00710 | 34993216 | Front Med (Lausanne) | Alterations in the Gut Microbiota and Hepatitis-B-Virus Infection in Southern Chinese Patients With Coexisting Non-Alcoholic Fatty Liver Disease and Type-2 Diabetes Mellitus. | 2021 | Details |
| A00711 | 34992694 | Dis Markers | Nonalcoholic Fatty Liver Disease-Associated Liver Fibrosis Is Linked with the Severity of Coronary Artery Disease Mediated by Systemic Inflammation. | 2021 | Details |
| A00712 | 34992579 | Front Endocrinol (Lausanne) | Association Between Diabetes Mellitus and All-Cause and Cardiovascular Mortality Among Individuals With Ultrasound-Defined Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A00713 | 34992541 | Front Pharmacol | Diammonium Glycyrrhizinate Ameliorates Obesity Through Modulation of Gut Microbiota-Conjugated BAs-FXR Signaling. | 2021 | Details |
| A00714 | 34992540 | Front Pharmacol | Transcriptomic Analysis Reveals the Protective Effects of Empagliflozin on Lipid Metabolism in Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A00716 | 34992072 | BMJ Open Gastroenterol | Impact of statin treatment on non-invasive tests based predictions of fibrosis in a referral pathway for NAFLD. | 2022 | Details |
| A00717 | 34990887 | Cell Mol Gastroenterol Hepatol | Hepatic Reduction in Cholesterol 25-Hydroxylase Aggravates Diet-induced Steatosis. | 2022 | Details |
| A00718 | 34990729 | Toxicol Appl Pharmacol | Whole life exposure to low dose cadmium alters diet-induced NAFLD. | 2022 | Details |
| A00719 | 34990473 | PLoS One | Depressive symptoms in non-alcoholic fatty liver disease are identified by perturbed lipid and lipoprotein metabolism. | 2022 | Details |
| A00720 | 34990079 | Liver Int | Adherence to the dietary approaches to stop hypertension diet and non-alcoholic fatty liver disease. | 2022 | Details |
| A00721 | 34990037 | Hepatology | Placebo effect on progression and regression in NASH: Evidence from a meta-analysis. | 2022 | Details |
| A00722 | 34988994 | Aliment Pharmacol Ther | Liver-related and extrahepatic events in patients with non-alcoholic fatty liver disease: a retrospective competing risks analysis. | 2022 | Details |
| A00723 | 34988895 | Obes Surg | Prevalence of Elevated Liver Stiffness Among Potential Candidates for Bariatric Surgery in the United States. | 2022 | Details |
| A00724 | 34988690 | Acta Diabetol | Sodium-glucose cotransporter protein-2 inhibitors and glucagon-like peptide-1 receptor agonists versus thiazolidinediones for non-alcoholic fatty liver disease: A network meta-analysis. | 2022 | Details |
| A00725 | 34988225 | Biomed Res Int | Target Deconvolution of Fenofibrate in Nonalcoholic Fatty Liver Disease Using Bioinformatics Analysis. | 2021 | Details |
| A00726 | 34988202 | Ann Transl Med | Y-box binding protein 1 regulates liver lipid metabolism by regulating the Wnt/β-catenin signaling pathway. | 2021 | Details |
| A00727 | 34987607 | Therap Adv Gastroenterol | Application of artificial intelligence in non-alcoholic fatty liver disease and liver fibrosis: a systematic review and meta-analysis. | 2021 | Details |
| A00728 | 34986838 | Cancer Cell Int | STK25 enhances hepatocellular carcinoma progression through the STRN/AMPK/ACC1 pathway. | 2022 | Details |
| A00729 | 34986792 | BMC Gastroenterol | Relationship of circulating total bilirubin, UDP-glucuronosyltransferases 1A1 and the development of non-alcoholic fatty liver disease: a cross-sectional study. | 2022 | Details |
| A00730 | 34986375 | J Affect Disord | Association between nonalcoholic fatty liver disease and depression: A systematic review and meta-analysis of observational studies. | 2022 | Details |
| A00731 | 34986301 | Endocrinol Metab (Seoul) | The Effects of PPAR Agonists on Atherosclerosis and Nonalcoholic Fatty Liver Disease in ApoE-/-FXR-/- Mice. | 2021 | Details |
| A00736 | 34983755 | BMJ Open | Does moderate alcohol consumption accelerate the progression of liver disease in NAFLD? A systematic review and narrative synthesis. | 2022 | Details |
| A00737 | 34983637 | Diabetol Metab Syndr | Overweight/obesity in adolescents with type 1 diabetes belonging to an admixed population. A Brazilian multicenter study. | 2022 | Details |
| A00738 | 34983596 | Chin Med | Traditional Chinese medicine Lingguizhugan decoction ameliorate HFD-induced hepatic-lipid deposition in mice by inhibiting STING-mediated inflammation in macrophages. | 2022 | Details |
| A00739 | 34983354 | Endocr Metab Immune Disord Drug Targets | Increasing risk factors of non-alcoholic fatty liver disease, a look into chronic periodontitis and insulin resistance. | 2022 | Details |
| A00740 | 34983091 | Korean J Radiol | Quantitative Evaluation of Hepatic Steatosis Using Advanced Imaging Techniques: Focusing on New Quantitative Ultrasound Techniques. | 2022 | Details |
| A00741 | 34982494 | J Intern Med | Soat2 ties cholesterol metabolism to β-oxidation and glucose tolerance in male mice. | 2022 | Details |
| A00742 | 34982430 | Eur Rev Med Pharmacol Sci | Intervention effects of four exercise modalities on nonalcoholic fatty liver disease: a systematic review and Bayesian network meta-analysis. | 2021 | Details |
| A00744 | 34981470 | Adv Exp Med Biol | The Effect of Herbal Medicine and Natural Bioactive Compounds on Plasma Adiponectin: A Clinical Review. | 2021 | Details |
| A00745 | 34981468 | Adv Exp Med Biol | Curcumin and Piperine Combination for the Treatment of Patients with Non-alcoholic Fatty Liver Disease: A Double-Blind Randomized Placebo-Controlled Trial. | 2021 | Details |
| A00746 | 34981443 | Clin J Gastroenterol | Hepatocellular carcinoma diagnosis using a novel electrochemiluminescence immunoassay targeting serum IgM-free AIM. | 2022 | Details |
| A00747 | 34981313 | Dig Dis Sci | Bariatric Surgery in NAFLD. | 2022 | Details |
| A00748 | 34981123 | Biosci Rep | Tandem mass tag-based proteomics analysis of type 2 diabetes mellitus with non-alcoholic fatty liver disease in mice treated with acupuncture. | 2022 | Details |
| A00749 | 34981106 | Food Funct | Supplementation with cyanidin and delphinidin mitigates high fat diet-induced endotoxemia and associated liver inflammation in mice. | 2022 | Details |